|
US5432198A
|
|
Vicinal-substituted carbocyclic compounds as therapeutic agents
|
|
ZA9405731B
|
|
Method for preparing and selecting pharmaceutically useful non-peptide compounds from a structurally diverse universal library
|
|
WO9504277A1
|
|
A method for preparing and selecting pharmaceutically useful non-peptide compounds from a structurally diverse universal library
|
|
AU6252794A
|
|
Balanoids
|
|
US5360818A
|
|
1,3-dioxane derivatives having protein kinase C inhibitory activity
|
|
AU4046493A
|
|
1,3,-propanediamine derivatives having protein kinase C inhibitory activity
|
|
WO9320695A1
|
|
Polyhydroxylated dibenz (c,e) azepines as protein kinase c inhibitors
|
|
US5292737A
|
|
N,N'-bis(sulfonamido)-2-amino-4-iminonaphthalen-1-ones and N,N'-bis(amido)-2-amino-4-iminonaphthalen-1-ones
|
|
AU2924492A
|
|
1,3-dioxane derivatives having protein kinase c inhibitory activity
|
|
AU2882892A
|
|
Novel furo-coumarinsulfonamides as protein kinase c inhibitors
|
|
WO9308120A1
|
|
2-aminopropan-1,3-diol chemotherapeutic agents
|
|
AU2504192A
|
|
Protein kinase c inhibition and novel compound balanol
|
|
FI923030A0
|
|
Bis- (hydroxialkylamino) - anthracinone hibitorer av proteinkinas c.
|
|
US5270310A
|
|
N-aminoalkyl amide inhibitors of protein kinase C
|
|
AU9039891A
|
|
Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c
|
|
US5216014A
|
|
Furo-coumarinsulfonamides as protein kinase C inhibitors
|
|
US5141957A
|
|
1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
|
|
US5204370A
|
|
Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase C
|
